Concept of biosimilar products in Jordan

Biologicals

Volumn 39, Issue 5, 2011, Pages 333-335

  Haddadin, Rania Dakhlallah ^a  

^a Technical Coordination and Consumer Education Section of the Jordanian Food and Drug Administration   (Jordan)

Author keywords

Biosimilars; Guidelines; Jordan

Indexed keywords

BIOLOGICAL PRODUCT;

ARTICLE; BIOTECHNOLOGY; DRUG EFFICACY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; JORDAN; PATENT; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

DRUG EVALUATION; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; GUIDELINES AS TOPIC; HUMANS; JORDAN; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY CONTROL;

EID: 80053567851     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.06.013     Document Type: Article

References (9)

1. Ajlouni K., Khader Y., Batieha A., Ajlouni H., El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. Journal of Diabetes and its Complications 2008, 22-5:317-324.
2. Mortality data in Jordan 2007, Ministry of Health.
3. Cancer incidence in Jordan 2008, Jordan Cancer Registry.
4. Cancer incidence in Jordan 2005, Jordan cancer Registry.
5. Lanthier M., Behrman R., Nardinelli C. Economic issues with follow-on protein products. Nature Reviews Drug Discovery 2008, 7-9:733-737.
6. Kelly J.J. Follow-on biologics: legal, scientific, and policy considerations. Journal of Health Care Law & Policy 2010, 13:257-268.
7. The law of unfair competition and trade secrets No. 15 of 2000.
8. Jordan Food and Drug Administration circular regarding the definition of new chemical entities number 2/9/1/17645 dated 16/6/2009 http://www.jfda.jo.
9. Provisional Law Number 80 of the year 2001. Drug and pharmacy law and its amendments of the year 2003. The Hashemite Kingdom of Jordan.